| Autor: |
Leitch, Derek, Barrans, Sharon L., Jack, Andrew S., Owen, Roger G. |
| Zdroj: |
Seminars in Oncology; April 2003, Vol. 30 Issue: 2 p161-164, 4p |
| Abstrakt: |
Indolent lymphoproliferative disorders such as Waldenstrom's macroglobulinemia (WM) are characterized by defective apoptosis, which leads to progressive accumulation of slowly dividing neoplastic lymphocytes. Activation of nuclear factor kappa B (NF?B) is considered to have a central pathogenic role in some hematological malignancies, including multiple myeloma, Hodgkin's disease, and extranodal marginal zone lymphoma (ENMZL). NF?B activation may inhibit apoptosis through the transactivation of genes such as Bcl-2 and may therefore be an important mechanism in indolent lymphoproliferative disorders, including WM. In order to assess this potential mechanism, we used immunohistochemistry to determine the presence and subcellular localisation of the major NF?B subunits p50 and p65. Nuclear staining of NF?B subunits (indicative of activation) was not seen in any of the 40 cases examined. Thirty-seven (95%) cases showed cytoplasmic positivity for both p50 and p65 and one case demonstrated cytoplasmic staining for p65 alone, while the two remaining cases showed complete absence of staining. We would therefore conclude that NF?B activation is not a feature of WM and that alternative mechanisms of apoptosis inhibition should be investigated in this disorder. Semin Oncol 30:161-164. © 2003 Elsevier Inc. All rights reserved. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
